Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4370 results

Sort By:

SKB264 Plus Inetetamab in HER2-Positive Metastatic Breast Cancer Patients Progressing After T-DXd Treatment

Study ID: NCT07182721
Start Date: 2025-09-30
End Date: 2029-02-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

48

Intervention / Treatment

SKB264 Plus Inetetamab

Sponsor

Fudan University

Source: clinicaltrials.gov

Share:
Add to list

Patterns of Neonatal Seizures

Study ID: NCT06726655
Start Date: 2025-10-01
End Date: 2026-11-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment
Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of a Therapeutic Education Program on Self-image in Patients With Chronic Inflammatory Rheumatic Diseases

Study ID: NCT07170826
Start Date: 2025-10
End Date: 2028-10
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Self questionnaire

interview

Sponsor

Public assistance - Paris hospitals

Source: clinicaltrials.gov

Share:
Add to list

Developing Empowering Smoking Cessation

Study ID: NCT06602076
Start Date: 2026-08
End Date: 2027-07
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

50

Intervention / Treatment

ECHO (Empowering Our Community & Health Outcomes)

Sponsor

University of Oklahoma

Source: clinicaltrials.gov

Share:
Add to list

Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

Study ID: NCT03676647
Start Date: 2025-12-25
End Date: 2028-09-25
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

22

Intervention / Treatment

Diagnostic DNA Methylation Signature

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia

Study ID: NCT06762548
Start Date: 2025-10-10
End Date: 2026-11-06
Study Type

Interventional

Study Phase

Phase3

No. of Participants

140

Intervention / Treatment

And-007

Placebo

Sponsor

Applied Biology, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Targeting Lifestyle to Improve Colorectal Cancer Screening

Study ID: NCT07135115
Start Date: 2025-10-15
End Date: 2041-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

16000

Intervention / Treatment

Digikost report baseline only

Digikost report intensive with individual counselling and webinars

Digikost report intensive

Sponsor

Norwegian Institute of Public Health

Source: clinicaltrials.gov

Share:
Add to list

ZIPPER™ Stent-Graft Trial for Aortic Arch Dissection

Study ID: NCT07170332
Start Date: 2025-09-30
End Date: 2032-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

127

Intervention / Treatment

ZIPPER™ Stent-Graft Trial for Aortic Arch Dissection

Sponsor

Hangzhou Endonom Medtech Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial

Study ID: NCT06999798
Start Date: 2025-10-02
End Date: 2026-07-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Diagnostic Mammography

Resection

Ultrasound Imaging

Twinkling Marker Placement

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Ketamine Assisted Psychotherapy for Treating Comorbid Chronic Pain and PTSD

Study ID: NCT07009158
Start Date: 2025-10
End Date: 2029-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Ketamine Infusion

Mindfulness-based cognitive therapy

Sponsor

Queen's University

Source: clinicaltrials.gov

Share:
Add to list